”Overall, 75 studies, comprising 32,298 patients, were included. Most studies (72/75) included patients with mCRPC. Higher ECOG PS was associated with a significant increase in mortality risk, with the highest estimate observed among patients with mCRPC with an ECOG PS of ≥2 versus <2 (hazard ratio [HR]: 2.10, 95% confidence interval [CI]: 1.87–2.37). When stratifying by study type, there was a higher risk estimate of mortality among patients with mCRPC with an ECOG PS of ≥1 versus <1 in real-world data studies (HR: 1.98, 95% CI: 1.72–2.26) compared with clinical trials (HR: 1.32, 95% CI: 1.13–1.54; p < 0.001). There were no significant differences in the HR of OS stratified by previous chemotherapy.”
Note that Grade 1 of the ECOG performance status is:
Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work
Note that Grade 2 of the ECOG performance status is:
Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours
The prognostic value of Eastern Cooperative Oncology Group performance status on overall survival among patients with metastatic prostate cancer: a systematic review and meta-analysis.
Assayag J, Kim C, Chu H, Webster J.
Front Oncol. 2023; 13: 1194718. Published online 2023 Dec 15. doi: 10.3389/fonc.2023.1194718
PMCID: PMC10757350PMID: 38162494
In other words keep fit and strong as long as you can!!